Showing results (341-350 of 377) with videos related to
Sort By:
Pageof 38
BMC Medicine|November 22, 2021
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineRebecca Webster, Silvana Sekuloski, Anand Odedra, et al.European Heart Journal|May 31, 2022
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trialSashiananthan Ganesananthan, Christopher A Rajkumar, Michael Foley, et al.JAMA Surgery|April 17, 2024
Placebo Control and Blinding in Randomized Trials of Procedural Interventions: A Systematic Review and Meta-RegressionChristopher A Rajkumar, Katharine E Thomas, Michael Foley, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetaseXi Ye, Lisl Y Esherick, Nutpakal Ketprasit, et al.HRB Open Research|November 13, 2023
Dementia research in Ireland: What should we prioritise?Carol Rogan, Bernadette Rock, Emer Begley, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2021
Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trialsChristopher A Rajkumar, Sashiananthan Ganesananthan, Yousif Ahmad, et al.Medchemcomm|December 14, 2018
Novel tricyclic glycal-based TRIB1 inducers that reprogram LDL metabolism in hepatic cellsMarek M Nagiec, Jeremy R Duvall, Adam P Skepner, et al.The Journal of Infectious Diseases|October 23, 2014
Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitorsAmanda K Lukens, Richard W Heidebrecht, Carol Mulrooney, et al.EMBO Molecular Medicine|August 4, 2025
Development of a novel therapy for systolic heart failureCorey Pollock, Xilun Wang, Hussam Alsaraji, et al.Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.Pageof 38